Search
forResearch 10 of 491
- Transgender and Migraine
- Migraine and the menopause transition
- The ATP sensitive potassium channel (KATP) is a novel target for migraine drug development
- Hair Transplantation in Migraine Headache Patients
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- A comparative assessment of propranolol, flunarizine and divalproex sodium in prophylactic therapy of migraine in a teaching Hospital in North India
- Pharmacologic Management of Acute Attacks of Migraine and Prevention of Migraine Headache
- Expert Opinion: Migraine, Psychiatric Comorbidities, and Treatment
- Evaluating the Prevalence of Migraine Headache among Patients with Female-Pattern Baldness
- Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →